Table 2.

Toxoplasma IgG and IgM positivity of patients and control groups

	Number of patients	Sex W/M	Age	IFAT and ELISA IgG(+)	IFAT and ELISA IgM(+)	Active disease significant with respect to
						Ig G(+)	IgM(+)
Cirrhosis	108	38/70	51.5 ± 10.2	74 (%68.5)a	2	31(%28.7)a	2
Control	50	19/31	40 ± 6.7	24 (%48)	-	4 (%8)	-

^aP < 0.05.